| # | Drug | Count |
|---|---|---|
| 0 | BRENTUXIMAB VEDOTIN | 86 |
| 1 | DOXORUBICIN | 39 |
| 2 | METHOTREXATE SODIUM | 39 |
| 3 | CYCLOPHOSPHAMIDE | 38 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 38 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 38 |
| 6 | METHOTREXATE | 36 |
| 7 | PREDNISOLONE | 35 |
| 8 | PREDNISOLONE ORAL | 35 |
| 9 | PREDNISOLONE ORAL SOLUTION | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRENTUXIMAB VEDOTIN | 86 | 0.0083 |
| 1 | ROMIDEPSIN | 8 | 0.0047 |
| 2 | L-ARGININE | 1 | 0.0028 |
| 3 | SODIUM PHENYLBUTYRATE | 1 | 0.0024 |
| 4 | BRIGATINIB | 6 | 0.0016 |
| 5 | MARAVIROC | 3 | 0.0013 |
| 6 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 1 | 0.0010 |
| 7 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 8 | TESTOSTERONE ENANTHATE | 1 | 0.0006 |
| 9 | CEFUROXIME AXETIL | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 86 |
| 1 | Corticosteroid [EPC] | 76 |
| 2 | Alkylating Drug [EPC] | 41 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 5 | Topoisomerase Inhibitor [EPC] | 16 |
| 6 | Purine Antimetabolite [EPC] | 15 |
| 7 | Interleukin-12 Antagonist [EPC] | 12 |
| 8 | Interleukin-23 Antagonist [EPC] | 12 |
| 9 | Kinase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 86 | 0.0083 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 2 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 6 | Antimalarial [EPC] | 2 | 0.0002 |
| 7 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 8 | Alkylating Drug [EPC] | 41 | 0.0002 |
| 9 | Purine Antimetabolite [EPC] | 15 | 0.0002 |